Shattuck Labs director files Form 3 with no holdings

Shattuck Labs, Inc. director Dr. Daniel G. Baker has filed an initial insider ownership report on Form 3 for Shattuck Labs, Inc. (STTK).

Rhea-AI Filing Summary

Shattuck Labs, Inc. director Dr. Daniel G. Baker has filed an initial insider ownership report on Form 3 for Shattuck Labs, Inc. (STTK). The filing identifies him as a director and indicates that the form is filed by one reporting person. In the remarks section, it explicitly states that no securities are beneficially owned, meaning Dr. Baker reported no direct or indirect ownership of Shattuck Labs securities as of the event date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the reporting person in the Shattuck Labs (STTK) Form 3 filing?

The reporting person is Dr. Daniel G. Baker, who is identified in the filing as a director of Shattuck Labs, Inc.

What does this Form 3 filing for Shattuck Labs (STTK) disclose about ownership?

The Form 3 states in the remarks that no securities are beneficially owned, indicating the reporting person held no Shattuck Labs securities as of the reported event.

Does Dr. Daniel G. Baker own any Shattuck Labs (STTK) stock according to this Form 3?

According to the remarks in the Form 3, no securities are beneficially owned, so Dr. Baker reported no beneficial ownership of Shattuck Labs securities at that time.

What is the relationship of Dr. Daniel G. Baker to Shattuck Labs (STTK)?

The filing identifies Dr. Daniel G. Baker as a director of Shattuck Labs, Inc., with no indication that he is an officer or 10% owner.

Were any transactions reported in this Shattuck Labs (STTK) Form 3?

No. The Form 3 contains no reported transactions and includes a remark that no securities are beneficially owned.

What is the purpose of this Form 3 for Shattuck Labs (STTK)?

Form 3 serves as an initial statement of beneficial ownership for insiders. In this case, it records that Dr. Daniel G. Baker, a director, reported no beneficial ownership of Shattuck Labs securities as of the event date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/02/2025 - 06:30 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Baker Daniel G.

(Last) (First) (Middle)

C/O SHATTUCK LABS, INC.

500 W. 5TH STREET, SUITE 1200

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/25/2025

3. Issuer Name and Ticker or Trading Symbol
Shattuck Labs, Inc. [ STTK ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Andrew R. Neill, Attorney-in-Fact for Dr. Daniel G. Baker	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.